Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19; Immunity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04448717
What this trial is testing

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

Who this might be right for
SARS-CoV 2COVID-19
University of Zurich 4,250
Not applicableUnknownNCT04896788
What this trial is testing

Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff

Who this might be right for
Hospital StaffVaccined Againt COVID-19
University Hospital, Clermont-Ferrand 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05633446
What this trial is testing

Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

Who this might be right for
CoronavirusSARS-CoV-2 InfectionCOVID-19
Gylden Pharma Ltd 110
Not applicableStudy completedNCT04596098
What this trial is testing

Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.

Who this might be right for
SARS-CoV 2
University Hospital, Grenoble 55
Not applicableStudy completedNCT05074706
What this trial is testing

Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study

Who this might be right for
Hematologic Diseases
University of Milano Bicocca 700
Large-scale testing (Phase 3)UnknownNCT05726084
What this trial is testing

Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

Who this might be right for
COVID-19Coronavirus InfectionsRespiratory Tract Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 16,304
Not applicableStudy completedNCT04646239
What this trial is testing

Biomarkers of Trained Immunity Following MMR Vaccination

Who this might be right for
Covid19
Washington University School of Medicine 96
Post-approval studies (Phase 4)Study completedNCT05970887
What this trial is testing

Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines

Who this might be right for
Immune ResponseSafety
Catholic Kwandong University 154
Not applicableStudy completedNCT05286242
What this trial is testing

Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

Who this might be right for
Multiple SclerosisAutoimmune Blistering DiseaseB-Cell Deficiency
Yale University 196
Not applicableWithdrawnNCT05682625
What this trial is testing

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Stanford University
Not applicableLooking for participantsNCT05973084
What this trial is testing

COVID-19 Transmission and Morbidity in Malawi

Who this might be right for
SARS CoV 2 InfectionSARS CoV 2 Vaccination
Boston University 1,500
Large-scale testing (Phase 3)UnknownNCT05163652
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Who this might be right for
SARS-CoV-2 Infection
Chinese Academy of Medical Sciences 432
Not applicableStudy completedNCT04843917
What this trial is testing

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Who this might be right for
Coronavirus 2019Healthcare WorkersVaccine
Hospital Italiano de Buenos Aires 100
Early research (Phase 1)Study completedNCT04495933
What this trial is testing

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Who this might be right for
SARS-CoV2Covid19
The University of Queensland 216
Not applicableEnded earlyNCT04852822
What this trial is testing

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
University of Washington 350
Not applicableUnknownNCT05172063
What this trial is testing

Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

Who this might be right for
Children With CancerSARS-CoV-2 Infection
Children's Cancer Hospital Egypt 57357 30
Large-scale testing (Phase 3)Study completedNCT04924660
What this trial is testing

Novel Experimental COVID-19 Therapies Affecting Host Response

Who this might be right for
COVID-19SARS-CoV-2 InfectionCoronavirus Infection
Sean Collins 1,060
Not applicableUnknownNCT05171959
What this trial is testing

Platelet and Immune Response in Covid-19 Vaccine

Who this might be right for
SARS-CoV-2 Vaccination
University of Roma La Sapienza 32
Testing effectiveness (Phase 2)UnknownNCT05046561
What this trial is testing

Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial

Who this might be right for
Covid19
Eyecheck, Inc. 598
Not applicableStudy completedNCT07610512
What this trial is testing

Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines

Who this might be right for
COVID-19Immune Response
Grape King Bio Ltd. 138
Next Page